SOTAC PHARMACEUTICALS
|
The Current P/S Ratio of SOTAC PHARMACEUTICALS is 1.36.
| Share Price | ₹117.0 | Apr 17,2026 |
| Market Cap | ₹129.9 Cr | |
| Sales-TTM | ₹95.6 Cr | TTM-Consolidated Results |
| Price/Sales | 1.36x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SOTAC PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹129.9 Cr] as on Apr 17,2026
(/) Sales [ ₹95.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.36x ]
Thus, for SOTAC PHARMACEUTICALS , the investors are currently willing to pay '1.36 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SOTAC PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of SOTAC PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of SOTAC PHARMACEUTICALS
PS Ratio Performance Analysis for SOTAC PHARMACEUTICALS
- SOTAC PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.53x.
- SOTAC PHARMACEUTICALS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SOTAC PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 1.35x.
- SOTAC PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does SOTAC PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SOTAC PHARMACEUTICALS | 95.6 | 1.36 | 129.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.04 | 400,209.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.17 | 166,750.0 |
| CIPLA LTD | 28,351.1 | 3.50 | 99,268.4 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.12 | 141,746.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.97 | 102,851.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.36 | 88,493.9 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.61 | 94,218.7 |
| LUPIN LTD | 26,150.5 | 4.07 | 106,459.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.39 | 79,436.2 |
| ABBOTT INDIA LTD | 6,824.1 | 7.96 | 54,353.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SOTAC PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.36x |
| Max industry PS | 16.17x |
| Median industry PS | 4.07x |
| Average industry PS | 6.05x |
You may also like the below Video Courses